Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent

Abstract The organophosphate (OP)‐hydrolyzing enzyme phosphotriesterase (PTE, variant L7ep‐3a) immobilized within a partially oxidized mesoporous silicon nanoparticle cage is synthesized and the catalytic performance of the enzyme@nanoparticle construct for hydrolysis of a simulant, dimethyl p‐nitro...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi‐Sheng Lu, Eduardo Reynoso Moreno, Yubin Huang, Ruhan Fan, Ashley T. Tucker, Linnzi K. Wright, Ronald A. Evans, Brooke M. Ahern, Donald E. Owens, Stephen A. Chappell, Dale J. Christensen, John Dresios, Michael J. Sailor
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202409535
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846106574668431360
author Yi‐Sheng Lu
Eduardo Reynoso Moreno
Yubin Huang
Ruhan Fan
Ashley T. Tucker
Linnzi K. Wright
Ronald A. Evans
Brooke M. Ahern
Donald E. Owens
Stephen A. Chappell
Dale J. Christensen
John Dresios
Michael J. Sailor
author_facet Yi‐Sheng Lu
Eduardo Reynoso Moreno
Yubin Huang
Ruhan Fan
Ashley T. Tucker
Linnzi K. Wright
Ronald A. Evans
Brooke M. Ahern
Donald E. Owens
Stephen A. Chappell
Dale J. Christensen
John Dresios
Michael J. Sailor
author_sort Yi‐Sheng Lu
collection DOAJ
description Abstract The organophosphate (OP)‐hydrolyzing enzyme phosphotriesterase (PTE, variant L7ep‐3a) immobilized within a partially oxidized mesoporous silicon nanoparticle cage is synthesized and the catalytic performance of the enzyme@nanoparticle construct for hydrolysis of a simulant, dimethyl p‐nitrophenyl phosphate (DMNP), and the live nerve agent VX is benchmarked against the free enzyme. In a neutral aqueous buffer, the optimized construct shows a ≈2‐fold increase in the rate of DMNP turnover relative to the free enzyme. Enzyme@nanoparticles with more hydrophobic surface chemistry in the interior of the pores show lower catalytic activity, suggesting the importance of hydration of the pore interior on performance. The enzyme@nanoparticle construct is readily separated from the neutralized agent; the nanoparticle is found to retain DMNP hydrolysis activity through seven decontamination/recovery cycles. The nanoparticle cage stabilizes the enzyme against thermal denaturing and enzymatic (trypsin) degradation conditions relative to free enzyme. When incorporated into a topical gel formulation, the PTE‐loaded nanoparticles show high activity toward the nerve agent VX in an ex vivo rabbit skin model. In vitro acetylcholinesterase (AChE) assays in human blood show that the enzyme@nanoparticle construct decontaminates VX, preserving the biological function of AChE when exposed to an otherwise incapacitating dose.
format Article
id doaj-art-86874606dd0748a4a99052ce21473bb2
institution Kabale University
issn 2198-3844
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-86874606dd0748a4a99052ce21473bb22024-12-27T13:00:47ZengWileyAdvanced Science2198-38442024-12-011148n/an/a10.1002/advs.202409535Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve AgentYi‐Sheng Lu0Eduardo Reynoso Moreno1Yubin Huang2Ruhan Fan3Ashley T. Tucker4Linnzi K. Wright5Ronald A. Evans6Brooke M. Ahern7Donald E. Owens8Stephen A. Chappell9Dale J. Christensen10John Dresios11Michael J. Sailor12Department of Chemistry and Biochemistry University of California San Diego La Jolla CA 92093 USALeidos 10260 Campus Point Drive San Diego CA 92121 United StatesDepartment of Chemistry and Biochemistry University of California San Diego La Jolla CA 92093 USAMaterials Science and Engineering Program University of California San Diego La Jolla CA 92093 USALeidos 10260 Campus Point Drive San Diego CA 92121 United StatesUS Army Combat Capabilities Development Command Chemical Biological Center 8938 N Kings Creek Rd., E3150 Gunpowder MD 21010 USAUS Army Combat Capabilities Development Command Chemical Biological Center 8938 N Kings Creek Rd., E3150 Gunpowder MD 21010 USAUS Army Combat Capabilities Development Command Chemical Biological Center 8938 N Kings Creek Rd., E3150 Gunpowder MD 21010 USATFF Pharmaceuticals 1751 River Run Fort Worth TX 76107 USALeidos 10260 Campus Point Drive San Diego CA 92121 United StatesTFF Pharmaceuticals 1751 River Run Fort Worth TX 76107 USALeidos 10260 Campus Point Drive San Diego CA 92121 United StatesDepartment of Chemistry and Biochemistry University of California San Diego La Jolla CA 92093 USAAbstract The organophosphate (OP)‐hydrolyzing enzyme phosphotriesterase (PTE, variant L7ep‐3a) immobilized within a partially oxidized mesoporous silicon nanoparticle cage is synthesized and the catalytic performance of the enzyme@nanoparticle construct for hydrolysis of a simulant, dimethyl p‐nitrophenyl phosphate (DMNP), and the live nerve agent VX is benchmarked against the free enzyme. In a neutral aqueous buffer, the optimized construct shows a ≈2‐fold increase in the rate of DMNP turnover relative to the free enzyme. Enzyme@nanoparticles with more hydrophobic surface chemistry in the interior of the pores show lower catalytic activity, suggesting the importance of hydration of the pore interior on performance. The enzyme@nanoparticle construct is readily separated from the neutralized agent; the nanoparticle is found to retain DMNP hydrolysis activity through seven decontamination/recovery cycles. The nanoparticle cage stabilizes the enzyme against thermal denaturing and enzymatic (trypsin) degradation conditions relative to free enzyme. When incorporated into a topical gel formulation, the PTE‐loaded nanoparticles show high activity toward the nerve agent VX in an ex vivo rabbit skin model. In vitro acetylcholinesterase (AChE) assays in human blood show that the enzyme@nanoparticle construct decontaminates VX, preserving the biological function of AChE when exposed to an otherwise incapacitating dose.https://doi.org/10.1002/advs.202409535acetylcholinesterase activity assaydermal protectionenzyme immobilizationenzyme stabilityphosphotriesterase variant L7ep‐3a
spellingShingle Yi‐Sheng Lu
Eduardo Reynoso Moreno
Yubin Huang
Ruhan Fan
Ashley T. Tucker
Linnzi K. Wright
Ronald A. Evans
Brooke M. Ahern
Donald E. Owens
Stephen A. Chappell
Dale J. Christensen
John Dresios
Michael J. Sailor
Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent
Advanced Science
acetylcholinesterase activity assay
dermal protection
enzyme immobilization
enzyme stability
phosphotriesterase variant L7ep‐3a
title Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent
title_full Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent
title_fullStr Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent
title_full_unstemmed Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent
title_short Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent
title_sort engineering a mesoporous silicon nanoparticle cage to enhance performance of a phosphotriesterase enzyme for degradation of vx nerve agent
topic acetylcholinesterase activity assay
dermal protection
enzyme immobilization
enzyme stability
phosphotriesterase variant L7ep‐3a
url https://doi.org/10.1002/advs.202409535
work_keys_str_mv AT yishenglu engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT eduardoreynosomoreno engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT yubinhuang engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT ruhanfan engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT ashleyttucker engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT linnzikwright engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT ronaldaevans engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT brookemahern engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT donaldeowens engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT stephenachappell engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT dalejchristensen engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT johndresios engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent
AT michaeljsailor engineeringamesoporoussiliconnanoparticlecagetoenhanceperformanceofaphosphotriesteraseenzymefordegradationofvxnerveagent